Literature DB >> 18359406

Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004.

Madhav V Rao1, Yang Qiu, Changchun Wang, George Bakris.   

Abstract

BACKGROUND: The prevalence and incidence of hypertension are increasing, and they correlate with the chronic kidney disease rate in the United States. Early identification and achievement of blood pressure goals may improve chronic kidney disease outcomes.
METHODS: In this cross-sectional study, subjects were participants in the Kidney Early Evaluation Program (KEEP), a voluntary community-based health-screening program enrolling individuals 18 years and older with diabetes, hypertension, or family history of kidney disease, diabetes, or hypertension, administered by the National Kidney Foundation; and the National Health and Nutrition Examination Survey (NHANES), administered by the National Center for Health Statistics. All studied individuals in both databases were US residents aged 18 years or older. We evaluated multiple variables for participants in KEEP 2000-2006 and participants in NHANES 1999-2004 in this logistic analysis.
RESULTS: Although distributions of hypertension were similar between databases, KEEP participants with cardiovascular risk factors, especially current smoking, have a greater prevalence of hypertension than similar NHANES participants. Of hypertensive participants, 35.8% were African American in KEEP data, and 13.2% in NHANES data. Associations with increased prevalence of hypertension were decreasing estimated glomerular filtration rate by increments of 10 mL/min/1.73 m(2), increasing age, obesity, African American race, and microalbuminuria. In both KEEP and NHANES data, study group participants younger than 46 years were more likely to have achieved goal blood pressure.
CONCLUSION: Several elements were identified by both registries as risk factors for linearly associated worsening of hypertension. In addition to the traditional risk factors of age, race, and geographic residence, such novel markers as microalbuminuria may also increase the risk.

Entities:  

Mesh:

Year:  2008        PMID: 18359406     DOI: 10.1053/j.ajkd.2007.12.012

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  51 in total

Review 1.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

Review 2.  Uric acid as a mediator of diabetic nephropathy.

Authors:  Diana I Jalal; David M Maahs; Peter Hovind; Takahiko Nakagawa
Journal:  Semin Nephrol       Date:  2011-09       Impact factor: 5.299

3.  The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

4.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin Exp Nephrol       Date:  2009-01-28       Impact factor: 2.801

5.  Hypertension: the message of World Kidney Day 2009.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

6.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

7.  Plasma bicarbonate and odds of incident hypertension.

Authors:  Ernest I Mandel; John P Forman; Gary C Curhan; Eric N Taylor
Journal:  Am J Hypertens       Date:  2013-08-13       Impact factor: 2.689

8.  Rate of change in renal function and mortality in elderly treated hypertensive patients.

Authors:  Enayet K Chowdhury; Robyn G Langham; Zanfina Ademi; Alice Owen; Henry Krum; Lindon M H Wing; Mark R Nelson; Christopher M Reid
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

9.  A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study.

Authors:  Shinichi Nishi; Eri Muso; Akira Shimizu; Hitoshi Sugiyama; Hitoshi Yokoyama; Yukio Ando; Shunsuke Goto; Hideki Fujii
Journal:  Clin Exp Nephrol       Date:  2016-08-25       Impact factor: 2.801

10.  Vascular Function and Uric Acid-Lowering in Stage 3 CKD.

Authors:  Diana I Jalal; Emily Decker; Loni Perrenoud; Kristen L Nowak; Nina Bispham; Tapan Mehta; Gerard Smits; Zhiying You; Douglas Seals; Michel Chonchol; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.